MedTrace Logo

Performance of the Dexcom Continuous Glucose Monitoring (CGM) System in Pregnant Women With Diabetes Mellitus

NCT04905628 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2022-02-21

No results posted yet for this study

Summary

Performance of the Dexcom Continuous Glucose Monitoring (CGM) System in Pregnant Women With Diabetes Mellitus

Conditions

Interventions

DEVICE

Dexcom CGM System

Dexcom CGM System

Sponsors & Collaborators

  • DexCom, Inc.

    lead INDUSTRY

Principal Investigators

  • Carol Levy, MD, CDCES · Icahn School of Medicine at Mount Sinai

  • Sarit Polsky,, MD, MPH · Barbara Davis Center

  • Florence Brown, MD · Joslin Diabetes Center

  • Kristin Castorino, DO · Sansum Diabetes Research Institute

  • Amy Valent, DO · Oregon Health and Science University

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-08
Primary Completion
2022-03-31
Completion
2022-04-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04905628 on ClinicalTrials.gov